Morgan Stanley initiates coverage on China Medical (Nasdaq: CMED) with an Outperform. Price target $54.

This article: 88 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE